Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Capillary Malformation”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Very early researchEnded earlyNCT01015300
What this trial is testing

Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease

Who this might be right for
HemangioblastomasVon Hippel Lindau Disease
Dartmouth-Hitchcock Medical Center 1
Not applicableUnknownNCT01974622
What this trial is testing

ICG-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities: A Pilot Study

Who this might be right for
Retinal Vascular Disorders
Manhattan Eye, Ear & Throat Hospital 30
Not applicableLooking for participantsNCT03233646
What this trial is testing

Retinal Imaging in Neurodegenerative Disease

Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentParkinson's Disease+12 more
Duke University 2,000
Testing effectiveness (Phase 2)Study completedNCT00975819
What this trial is testing

Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies

Who this might be right for
Kaposiform HemangioendotheliomasTufted AngiomaCapillary Venous Lymphatic Malformation+6 more
Denise Martin Adams 61
Testing effectiveness (Phase 2)Study completedNCT00199771
What this trial is testing

Hypertonic Saline Dextran in Pediatric Cardiac Surgery

Who this might be right for
Heart Defects, CongenitalTransposition of Great VesselsHeart Septal Defects, Ventricular+1 more
Oslo University Hospital 14
Not applicableEnded earlyNCT04125290
What this trial is testing

US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI)

Who this might be right for
Hairy Cell Leukemia
AstraZeneca 2
Not applicableStudy completedNCT05934578
What this trial is testing

Lymphatic Function in Patients With Fontan Circulation: Effect of Physical Training

Who this might be right for
Univentricular HeartCongenital Heart DiseaseLymphatic Abnormalities+3 more
University of Sao Paulo 20
Not applicableLooking for participantsNCT06915649
What this trial is testing

Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, and Educational Approach

Who this might be right for
Hippocampal SclerosisDysembryoplastic Neuroepithelial TumorCortical Dysplasia+6 more
University Hospital, Montpellier 3,504
Not applicableStudy completedNCT03652181
What this trial is testing

CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness

Who this might be right for
CCMCavernomaCerebral Cavernous Malformation+4 more
University of Chicago 123
Not applicableStudy completedNCT01817062
What this trial is testing

Neonates With Very Low Birth Weight and Surgery Therapy of Acute Abdomen

Who this might be right for
Very Low Birth Weight
Charite University, Berlin, Germany 89
Not applicableStudy completedNCT00970970
What this trial is testing

Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease

Who this might be right for
Von Hippel-Lindau DiseaseHemangioblastomaRenal Cell Carcinoma+2 more
University Medical Center Groningen 22
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Testing effectiveness (Phase 2)Looking for participantsNCT06789913
What this trial is testing

Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

Who this might be right for
PIK3CA-Related Overgrowth Spectrum (PROS)Lymphatic MalformationsVascular Malformations+5 more
Relay Therapeutics, Inc. 277
Testing effectiveness (Phase 2)Looking for participantsNCT05577754
What this trial is testing

Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP)

Who this might be right for
Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)
Centre Hospitalier Universitaire Dijon 20
Early research (Phase 1)Study completedNCT02108002
What this trial is testing

Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)

Who this might be right for
Von Hippel-Lindau Disease
National Institute of Neurological Disorders and Stroke (NINDS) 7
Testing effectiveness (Phase 2)UnknownNCT02883023
What this trial is testing

Electrosclerotherapy for Capillary Malformations

Who this might be right for
Capillary MalformationsVascular Malformations
Sophie Horbach 20
Not applicableUnknownNCT04292483
What this trial is testing

Pulmonary Capillary Recruitment in Fontan Patients

Who this might be right for
Congenital Heart Disease
Jewish General Hospital 15
Not applicableTemporarily pausedNCT05484219
What this trial is testing

Functional Navigation in Surgery of Cerebral Tumors and Vascular Malformations

Who this might be right for
Tumor, BrainArteriovenous MalformationsCavernoma
Sklifosovsky Institute of Emergency Care 50
Not applicableStudy completedNCT00365118
What this trial is testing

Treatment of Naevus Flammeus Using Intense Pulsed Light and Pulsed Dye Laser

Who this might be right for
Port-Wine Stain
Bispebjerg Hospital
Testing effectiveness (Phase 2)Study completedNCT02859441
What this trial is testing

A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab

Who this might be right for
Von Hippel-Lindau Syndrome
National Eye Institute (NEI) 3
Load More Results